351 related articles for article (PubMed ID: 26943478)
41. Efficient synthesis of novel dialkyl-3-cyanopropylphosphate derivatives and evaluation of their anticholinesterase activity.
Aouani I; Sellami B; Lahbib K; Cavalier JF; Touil S
Bioorg Chem; 2017 Jun; 72():301-307. PubMed ID: 28500956
[TBL] [Abstract][Full Text] [Related]
42. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group.
Gao XH; Zhou C; Liu HR; Liu LB; Tang JJ; Xia XH
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600
[TBL] [Abstract][Full Text] [Related]
43. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Soyer Z; Uysal S; Parlar S; Tarikogullari Dogan AH; Alptuzun V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):13-19. PubMed ID: 27766908
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and evaluation of novel 2-(aminoalkyl)-isoindoline-1,3-dione derivatives as dual-binding site acetylcholinesterase inhibitors.
Ignasik M; Bajda M; Guzior N; Prinz M; Holzgrabe U; Malawska B
Arch Pharm (Weinheim); 2012 Jul; 345(7):509-16. PubMed ID: 22467516
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and molecular modeling of isothiochromanone derivatives as acetylcholinesterase inhibitors.
Shuai W; Li W; Yin Y; Yang L; Xu F; Xu S; Yao H; Zhu Z; Xu J
Future Med Chem; 2019 Oct; 11(20):2687-2699. PubMed ID: 31596141
[No Abstract] [Full Text] [Related]
47. Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives.
Saeedi M; Mohtadi-Haghighi D; Mirfazli SS; Mahdavi M; Hariri R; Lotfian H; Edraki N; Iraji A; Firuzi O; Akbarzadeh T
Chem Biodivers; 2019 Feb; 16(2):e1800433. PubMed ID: 30460743
[TBL] [Abstract][Full Text] [Related]
48. Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesterase.
Wiemann J; Loesche A; Csuk R
Bioorg Chem; 2017 Oct; 74():145-157. PubMed ID: 28797788
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.
Skrzypek A; Matysiak J; Niewiadomy A; Bajda M; Szymański P
Eur J Med Chem; 2013 Apr; 62():311-9. PubMed ID: 23376249
[TBL] [Abstract][Full Text] [Related]
50. In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors.
Telpoukhovskaia MA; Patrick BO; Rodríguez-Rodríguez C; Orvig C
Bioorg Med Chem Lett; 2016 Mar; 26(6):1624-1628. PubMed ID: 26869193
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and anticholinergic activity of 4-hydroxycoumarin derivatives containing substituted benzyl-1,2,3-triazole moiety.
Bagheri SM; Khoobi M; Nadri H; Moradi A; Emami S; Jalili-Baleh L; Jafarpour F; Homayouni Moghadam F; Foroumadi A; Shafiee A
Chem Biol Drug Des; 2015 Nov; 86(5):1215-20. PubMed ID: 26010139
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
[TBL] [Abstract][Full Text] [Related]
56. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
[TBL] [Abstract][Full Text] [Related]
57. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK
Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
